Booy R, Haworth E A, Ali K A, Chapel H M, Moxon E R
Research Centre for Child Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
Arch Dis Child. 2005 Jun;90(6):589-91. doi: 10.1136/adc.2004.064469.
To determine the immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b (Hib) in Asian infants born in the UK, and whether maternal antibody suppression occurs.
A cohort study with 80% power, within 95% confidence limits, to show that 80% or fewer Asian infants would respond with an anti-PRP antibody concentration >0.15 microg/ml. Infants of South Asian origin born in Berkshire were enrolled at two general practices in Reading: 41 Asian families sequentially asked to participate within 2 weeks of birth; 36 infants were enrolled and 34 completed the study. Main outcome measures were: antibody concentration against diphtheria, tetanus, and Hib expressed as geometric mean titres (GMT) and proportion of infants about a threshold protective antibody concentration.
Median age for completing primary vaccination course was 5 months. All 34 achieved anti-PRP antibody concentration of >0.15 microg/ml, 33 were >1.0 microg/ml, and the GMT was 15.0 microg/ml. All infants developed protective antibody concentration >0.1 IU/ml for tetanus and diphtheria; the respective GMTs were 1.94 and 5.57 IU/ml. Infants with high (>0.25 IU/ml) antibody concentrations against diphtheria and tetanus at 2 months achieved lower antibody concentrations after their three dose course than those with low concentrations (<0.1 IU/ml) (p = 0.06 and 0.03, respectively).
Despite evidence for maternal antibody suppression of the response to tetanus and diphtheria vaccination, excellent antibody responses were achieved by routine vaccination according to the accelerated schedule. High vaccine coverage should be encouraged to provide protection against the possibility of imported infection.
确定在英国出生的亚洲婴儿中,白喉、破伤风和b型流感嗜血杆菌(Hib)常规疫苗接种的免疫原性,以及是否发生母体抗体抑制。
进行一项队列研究,具有80%的检验效能,在95%置信区间内,以表明80%或更少的亚洲婴儿抗PRP抗体浓度>0.15微克/毫升时会产生反应。在雷丁的两家全科诊所招募了伯克郡出生的南亚裔婴儿:41个亚洲家庭在婴儿出生后2周内被依次邀请参与;36名婴儿被纳入研究,34名完成了研究。主要观察指标为:以几何平均滴度(GMT)表示的抗白喉、破伤风和Hib抗体浓度,以及达到阈值保护性抗体浓度的婴儿比例。
完成初级疫苗接种疗程的中位年龄为5个月。所有34名婴儿的抗PRP抗体浓度均>0.15微克/毫升,33名>1.0微克/毫升,GMT为15.0微克/毫升。所有婴儿破伤风和白喉的保护性抗体浓度均>0.1国际单位/毫升;各自的GMT分别为1.94和5.57国际单位/毫升。2个月时抗白喉和破伤风抗体浓度高(>0.25国际单位/毫升)的婴儿在完成三剂疗程后的抗体浓度低于浓度低(<0.1国际单位/毫升)的婴儿(p值分别为0.06和0.03)。
尽管有证据表明母体抗体抑制了对破伤风和白喉疫苗接种的反应,但按照加速程序进行常规疫苗接种仍获得了良好的抗体反应。应鼓励高疫苗接种覆盖率,以防范输入性感染的可能性。